Korean J Pediatr Gastroenterol Nutr.  2011 Sep;14(3):232-244. 10.5223/kjpgn.2011.14.3.232.

Organic Upper Digestive Diseases in Children with Chronic Abdominal Pain

• Chang SH

• KMID: 2276882
• DOI: http://doi.org/10.5223/kjpgn.2011.14.3.232

Abstract

Organic diseases are prevalent in about 5 to 10% of children with chronic abdominal pain. The most common diseases of the upper digestive tract include gastroesophageal reflux disease (GERD), chronic gastritis with or without Helicobacter pylori (H. pylori), and peptic ulcer. The H. pylori infections acquired during childhood persist lifelong without eradication. Although the majority of H. pylori infected children remain asymptomatic, H. pylori infection may cause various digestive and extra-digestive diseases. There are still debates about a causal relationship between H. pylori-gastritis and abdominal symptoms in the absence of peptic ulcer disease. The number of Korean children infected with antibiotic resistant H. pylori is increasing even though the prevalence decreases after eradication. The choices of rescue therapy are limited in children after eradication failure. Antioxidant supplements with regimens against H. pylori have been tried with limited effects. Here I wanted to review the findings of recent reports on common upper digestive diseases such as GERD, peptic ulcer, and H. pylori infection in children with chronic abdominal pain.

Keyword

Chronic abdominal pain; Organic disease; H. pylori infection

MeSH Terms

Abdominal Pain
Child
Gastritis
Gastroesophageal Reflux
Gastrointestinal Tract
Helicobacter pylori
Humans
Peptic Ulcer
Prevalence

Reference

1. Seo JK, Chi JG, Kim EC. Gastrofiberscopic findings and Helicobacter pylori gastritis in children with recurrent abdominal pain. J Korean Pediatr Soc. 1992. 35:1646–1656.

2. Kalach N, Bonkems P, Koletzko S, Mourad-Baars P, Shcherbakov P, Celinska-Cedro D, et al. Frequency and risk factors of gastric and duodenal ulcers or erosions in children-a prospective 1-month European multicenter study. Eur J Gastroenterol Hepatol. 2010. 22:1174–1181.

3. Thakkar K, Dorsey F, Gilger MA. Impact of endoscopy on management of chronic abdominal pain in children. Dig Dis Sci. 2011. 56:488–493.

4. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006. 101:1900–1920. quiz 1943.

5. Nelson SP, Chen EH, Syniar GM, Christoffel KK. the Pediatric Practice Research Group. Prevalence of symptoms of gastroesophageal reflux during childhood. A pediatric practice-based survey. Arch Pediatr Adolesc Med. 2000. 154:150–154.

6. Kwon HJ, Yi DY, Ryoo E, Cho KH, Son DW, Tcha H. Prevalence and risk factors associated with esophagitis in children with abdominal pain. Korean J Pediatr Gastroenterol Nutr. 2008. 11:103–109.

7. Gold BD. Outcomes of pediatric gastroesophageal reflux disease: In the first year of life, childhood and adults. Oh, and should we really leave Helicobacter pylori alone? J Pediatr Gastroenterol Nutr. 2003. 37:S33–S39.

8. Vandenplas Y, Rudolph CD, Di Lorenzo C, Hasall E, Liptak G, Mazur L, et al. Pediatric gastroesophageal reflux clinical practice guidelines: Joint recommendations of the North American Society for Pediatric Gastroenteroloty, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (EPSGHAN). J Pediatr Gastroenterol Nutr. 2009. 49:498–547.

9. Boccia G, Manguso F, Miele E, Buonavolontá R, Staiano A. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable? Am J Gastroenterol. 2007. 102:1291–1297.

10. Tam YH, Lee KH, To YF, Chan KW, Cheung ST. Helicobacter pylori-positive versus Helicobacter pylori-negative idiopathic peptic ulcers in children with their long-term outcomes. J Pediatr Gastroenterol Nutr. 2009. 48:299–305.

11. Oderda G, Mura S, Valori A, Brustia R. Idiopathic peptic ulcers in children. J Pediatr Gastroenterol Nutr. 2009. 48:268–270.

12. Seo JK, Yang HR. Characteristic features of H. pylori infection in children. Hanyang Med Rev. 2007. 27:65–75.

13. Kim NY, Kim JJ, Choe YH, Kim HS, Kim JI, Chung IS. Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea. Korean J Gastroenterol. 2009. 54:269–278.

14. Seo JK, Ko JS, Choi KD. Serum ferritin and Helicobacter pylori infection in children: a sere-epidemiologic study in Korea. J Gastroenterol Hepatol. 2002. 17:754–757.

15. Handa O, Naito Y, Yoshikawa T. Helicobacter pylori: a ROS-inducing bacterial species in the stomach. Inflamm Res. 2010. 59:997–1003.

16. Ko JS, Chung JY, Bae SH, Kim EJ, Seo JK. Relation between recurrent abdominal pain and Helicobacter pylori infection and the role of cag A and vac A in pediatric Helicobacter pylori infection. Korean J Gastroenterol. 2001. 37:167–172.

17. Ko JY, Kim YJ, Park HY, Choe YH, Jeon BH, Oh YJ, et al. Genotypes of the Helicobacter pylori vac A signal sequence differ with age in Korea. Korean J Helicobacter Up Gastrointest Res. 2004. 4:15–20.

18. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007. 56:772–781.

19. Seo JK. Role of endoscopy in the diagnosis and management of peptic ulcer disease in children. Sin Paediatr J. 1999. 41:264–271.

20. Choe YH, Ko JS, Kim SY, Yoo YM, Seo JK. The eradication of Helicobacter pylori in the duodenal ulcer and the duodenal recurrence. Korean J Pediatr Gastroenterol Nutr. 1998. 1:30–36.

21. Na SY, Seo JK. Helicobacter pylori infection in children with recurrent abdominal pain. Korean J Pediatr Gastroenterol Nutr. 2005. 8:1–11.

22. Spee LAA, Madderom MB, Pijpers M, Leeuwen YV, Berger MY. Association between Helicobacter pylori and gastrointestinal symptoms in children. Pediatrics. 2010. 125:e651–e669.

23. Yuan W, Yumin L, Kehu Y, Bin M, Quanlin G, Donghai W, et al. Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials. Scand J Gastroenterol. 2010. 45:665–676.

24. Qu XH, Huang XL, Xiong P, Zhu CY, Huang YL, Lu LG, et al. Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis. World J Gastroenterol. 2010. 16:886–896.

25. Thankachan P, Muthayya S, Sierksma A, Eilander A, Thomas T, Duchateau GS, et al. Helicobacter pylori infection does not influence the efficacy of iron and vitamin B12 fortification in marginally nourished Indian children. Eur J Clin Nutr. 2010. 64:1101–1107.

26. Choe YH, Kim SK, Hong YC. The relationship between Helicobacter pylori infection and iron-deficiency: seroprevalence study in 937 pubescent children. Arch Dis Child. 2003. 88:178.

27. Choe YH, Kim SK, Son BK, Lee DH, Hong YC, Pai SH. Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. Helicobacter. 1999. 4:135–139.

28. Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol. 2010. 16:5181–5194.

29. Kindermann A, Lopes AI. Helicobacter pylori in Pediatrics. Helicobacter. 2009. 14:Suppl 1. 52–57.

30. Windle HJ, Kelleher D, Crabtree JE. Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle? Pediatrics. 2007. 119:e754–e759.

31. Choe YH, Lee JE, Kim SK, Hong YC. Helicobacter pylori infection with iron deficiency anemia and subnormal growth at puberty. Arch Dis Child. 2000. 82:136–140.

32. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010. 15:1–20.

33. Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011. Publish Ahead of Print Version Available at http://www.naspghan.org.

34. Choi JG, Jang JY, Kim JS, Park HY, Choe YH, Kim KM. Efficacy of two triple eradication regimens in children with Helicobacter pylori infection. J Korean Med Sci. 2006. 21:1037–1040.

35. Oderda G, Shcherbakov P, Bontems P, Urruzuno P, Romano C, Gottrand F, et al. Results from the pediatric European register for treatment of Helicobacter pylori (PERTH). Helicobacter. 2007. 12:150–156.

36. Ko JS, Yang HR, Seo JK. Detection of 23S rRNA mutation associated with clarithromycin resistance in children with Helicobacter pylori infection. Korean J Pediatr Gastroenterol Nutr. 2004. 7:137–142.

37. Kim YM, Lee YJ, Oh SH, Sung H, Kim M, Kim KM. Antimicrobial resistance of Helicobacter pylori isolated from Korean children. Korean J Pediatr Gastroenterol Nutr. 2011. 14:45–51.

38. Chiesa C, Pacifico L, Anania C, Poggiogalle E, Chiarelli F, Osborn JF. Helicobacter pylori therapy in children: overview and challenge. Int J Immunopathol Pharmacol. 2010. 23:405–416.

39. Orenstein SR. Clinical trials report: optimal treatment of Helicobacter pylori gastric infection in children. Curr Gastroenterol Rep. 2010. 12:157–159.

40. Dore MP, Leandro G, Realdi G, Sepulveda AR, Grahan DY. Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci. 2000. 45:68–76.

41. Schwarzer A, Urruzuno P, Iwanczak B, Martinez-Gomez ME, Kalach N, Roma-Giammikon E, et al. New effective treatment regimen for children infected with a double resistant Helicobacter pylori strain. J Pediatr Gastroenterol Nutr. 2011. 52:424–428.

42. Francavilla R, Lionetti E, Castellaneta SP, Magista AM, Boscarelli G, Piscitelli D, et al. Improved efficacy of 10-day sequential treatment for Helicobacter pylori eradication in children; a randomized trial. Gastroenterology. 2005. 129:1414–1419.

43. Francavilla R, Lionetti E, Castellaneta S, Margiotta M, Piscitelli D, Lorenzo L, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. J Pediatr. 2010. 157:228–232.

44. Lionetti E, Indrio F, Pavone L, Borrelli G, Cavallo L, Franvavilla R. Role of probiotics in pediatric patients with Helicobacter pylori infection: a comprehensive review of the literature. Helicobacter. 2010. 15:79–87.

45. Akcam M. Helicobacter pylori and micronutrients. Indian Pediatrics. 2010. 47:119–126.

46. DovhanJ J, Kljakc K, Dodig-Curkovic K, Curković M, Volarević M, Marjanović K. Helicobacter pylori, zinc, and iron in oxidative stress-induced injury of gastric mucosa. Mini Rev Med Chem. 2009. 9:26–30.

47. Salgueiro J, Zubillaga M, Goldman C, Barrado A, Martinez Sarrasague M, Leonardi N, et al. Review article: is there a link between micronutrient malnutrition and Helicobacter pylori infection? Aliment Pharmacol Ther. 2004. 20:1029–1034.

48. Park JH, Kim SY, Kim DW, Lee WG, Rhee KH, Youn HS. Correlation between Helicobacter pylori infection and vitamin C levels in whole blood, plasma, and gastric juice in Korean children. J Pediatr Gastroenterol Nutr. 2003. 37:53–62.

49. Jarosz M, Dzieniszewski J, Dabrowska-Ufniarz E, Wartanowicz M, Ziemlanski S, Reed PI. Effects of high dose vitamin C treatment on Helicobacter pylori infection and total vitamin C concentration in gastric juice. Eur J Cancer Prev. 1998. 7:449–454.

50. Chuang CH, Sheu BS, Kao AW, Cheng HC, Huang AH, Yang HB, et al. Adjuvant effect of vitamin C on Omeprzole-Amoxicillin-Clarithromycin triple therapy for Helicobacter pylori eradication. Hepato-Gastroenterology. 2007. 54:320–324.

51. Zojaji H, Talaie R, Mirsattari D, Haghazali M, Molaei M, Mohsenian N, et al. The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation. Dig Liver Dis. 2009. 41:644–647.

52. Sezikli M, Çetinkaya ZA, Sezikli H, Güzelbulut F, TiftikÇi A, Ince AT, et al. Oxidative stress in Helicobacter pylori infection: Does supplementation with vitamin C and E increase the eradication rate? Helicobacter. 2009. 14:280–285.

53. Chuang CH, Sheu BS, Huang AH, Yang HB, Wu JJ. Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection. Helicobacter. 2002. 7:310–316.

54. Rokkas T, Papatheodorou G, Karameris A, Mavrogeorgis A, Kalogeropoulos N, Giannikos N. Helicobacter pylori infection and gastric juice vitamin C levels; impact of eradication. Dig Dis Sci. 1995. 40:615–621.

55. Hep A, Posisilova J, Dolina J, Prasek J, Dite P. Levels of vitamins A, E, and C in serum and gastric juice in relation to gastric mucosa and occurrence of Helicobacter pylori. Vnitr Lek. 1998. 44:396–399.

56. Zhang YY, Xia HH, Zhuang ZH, Zhong J. Review article: 'true' re-infection of Helicobacter pylori after successful eradication--worldwide annual rates, risk factors and clinical implications. Aliment Pharmacol Ther. 2009. 29:145–160.

57. Shim JO, Seo JK. Helicobacter pylori reinfection rate by a 13C-urea breath test and endoscopic biopsy tests in Korean children. Korean J Pediatr. 2006. 49:268–272.

58. Broussard CS, Goodman KJ, Phillips CV, Smith MA, Fischbach LA, Day RS, et al. Antibiotics taken for other illnesses and spontaneous clearance of Helicobacter pylori infection in children. Pharmacoepidemiol Drug Saf. 2009. 18:722–729.

59. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter. 2007. 12:89–102.